| NCT ID | NCT03526029 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Trauma, Multiple |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2015-01-01 |
| Primary Completion | 2040-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2015-01-01 with a primary completion date of 2040-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Swiss Conference of Cantonal Health Directors has transferred the planning of highly specialized medicine to a specialized body under the direction of the Swiss Academy of Sciences. This specialist body has defined the treatment of critically ill as part of highly specialized medicine and founded the Swiss Trauma Registry at 12 hospitals in Switzerland. The registry is designed to provide a consistent and standardized approach and treatment outcomes in the short and long term quality control and as a basis for planning highly specialized medicine.
Eligibility Criteria
Inclusion Criteria: * injury severity code \> 16 and 7 or abbreviated injury scale \>3 for region of skull and brain Exclusion Criteria: * patients who will transferred in a burn unit * drowned patients
Contact & Investigator
Nicolas Bless, Prof MD
✉ nicolas.bless@usb.chAndreas Marc Müller, Prof MD
PRINCIPAL INVESTIGATOR
University Hospital, Basel, Switzerland
Frequently Asked Questions
Who can join the NCT03526029 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying Trauma, Multiple. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03526029 currently recruiting?
Yes, NCT03526029 is actively recruiting participants. Contact the research team at nicolas.bless@usb.ch for enrollment information.
Where is the NCT03526029 trial being conducted?
This trial is being conducted at Aarau, Switzerland, Basel, Switzerland, Bern, Switzerland, Chur, Switzerland and 8 additional locations.
Who is sponsoring the NCT03526029 clinical trial?
NCT03526029 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Andreas Marc Müller, Prof MD at University Hospital, Basel, Switzerland. The trial plans to enroll 2,000 participants.